Skip to content

Overcoming Addictions: A Randomized Clinical Trial of a Web Application Based on SMART Recovery

Overcoming Addictions: A Randomized Clinical Trial of a Web Application Based on SMART Recovery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01389297
Enrollment
189
Registered
2011-07-08
Start date
2011-09-30
Completion date
2013-06-30
Last updated
2014-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcoholism

Keywords

alcohol dependence intervention, Internet delivered intervention, alcohol dependence treatment, Internet delivered treatment

Brief summary

The objective of this research project is to develop, evaluate, and disseminate an Internet-based (web) application for SMART Recovery: Overcoming Addictions (OA). OA will be based on the four point cognitive-behavioral program for SMART Recovery (www.smartrecovery.org). The goal of the OA program is to help users learn cognitive and behavioral skills to abstain from drinking, drug use, and problem gambling. The investigators will evaluate the effectiveness of the OA web application for heavy drinkers in a randomized clinical trial (RCT) with follow-ups at 3- and 6-months. The study design has three conditions: 1) participation in face-to-face SMART Recovery meetings alone; 2) use of the OA web application as a stand-alone intervention; and 3) combining the OA web application with participation in face-to-face SMART Recovery meetings. Study Hypotheses: 1. All three groups will reduce their alcohol consumption, drug use (if any), and alcohol/drug-related problems relative to their baseline levels at the 3- and 6-month post-baseline assessments. 2. The OA only group (Experimental group 1) will show a greater reductions in drinking, drug use (if any), and alcohol/drug-related problems relative to the face-to-face only (Control) group. 3. The OA + face-to-face group (Experimental group 2) will have better outcomes on drinking and drug use variables compared to the Control group.

Interventions

BEHAVIORALOvercoming Addictions web application

Logging into and using the web application at least weekly during the course of the study

BEHAVIORALSMART Recovery face-to-face meetings

Attending these meetings at least weekly in frequency

Sponsors

National Institute on Alcohol Abuse and Alcoholism (NIAAA)
CollaboratorNIH
Behavior Therapy Associates, LLP
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Minimum age 18. 2. Positive response to quantity/frequency screening questions regarding heavy drinking in the previous 90 days. 3. An Alcohol Use Disorders Identification Test (AUDIT) score of 8+. 4. Is a new member of SMART Recovery(i.e., just joining or joined within the last 4 weeks). 5. Has a computer at home with Internet access. 6. Has a primary focus on abstaining from drinking.

Exclusion criteria

1. Court mandated 1st time DWI offenders. 2. Current diagnosis of drug dependence or consider themselves to be drug dependent. 3. Current evidence of uncontrolled psychosis or bipolar disorder. 4. Evidence of significant cognitive impairment from brain dysfunction. 5. English reading level below the 8th grade. 6. Unwilling or unable to be available for 3 and 6 month post-baseline assessments. 7. Unwilling or unable to provide one Significant Other (SO) for corroboration of participant's self-report of drinking and drug use (if any).

Design outcomes

Primary

MeasureTime frameDescription
Quantity/frequency of alcohol use: Form 903 monthsQuantity/frequency of alcohol use over the course of 90 days prior to the baseline assessment.

Secondary

MeasureTime frameDescription
Quantity and frequency of alcohol and drug related problems using the Inventory of Drug (and Alcohol) Use Consequences (InDuC)3 monthsThe quantity and frequency of alcohol and drug related problems in the 90 days from the baseline assessment.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026